Ustekinumab and Vedolizumab Are Equally Safe and Effective in Elderly Crohn’s Disease Patients
Gerum Gashaw Gebeyehu, J. Fiske, Eleanor Liu, Jimmy K. Limdi, Giacomo Broglio, Christian P. Selinger, Violeta Razsanskaite, Philip J Smith, Paul Flanagan, Sreedhar Subramanian
Topics & Concepts
VedolizumabUstekinumabMedicineCrohn's diseaseInternal medicineFaecal calprotectinDiscontinuationPropensity score matchingCohort studyInflammatory bowel diseaseCohortCalprotectinAdalimumabDiseaseInflammatory Bowel DiseaseRheumatoid Arthritis Research and TherapiesBiosimilars and Bioanalytical Methods